Clinical Trial Update: Add-On Therapy to Risperidonein Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

Reports on a completed Phase 2/Phase 3 trial evaluating an add-on therapy to risperidone for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED